Cargando…

Genomic Identification of RNA Editing Through Integrating Omics Datasets and the Clinical Relevance in Hepatocellular Carcinoma

RNA editing is a widespread post-transcriptional mechanism to introduce single nucleotide changes to RNA in human cancers. Here, we characterized the global RNA editing profiles of 373 hepatocellular carcinoma (HCC) and 50 adjacent normal liver samples from The Cancer Genome Atlas (TCGA) and reveale...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Juan, Wang, Lu, Wang, Fangbin, Liu, Jian, Bai, Zhenyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033493/ https://www.ncbi.nlm.nih.gov/pubmed/32117713 http://dx.doi.org/10.3389/fonc.2020.00037

Ejemplares similares

Multiple Omics Integration Reveals Key Circular RNAs in Hepatocellular Carcinoma
por: Huang, Zi-Li, et al.
Publicado: (2021)

Multi-omics Analysis of Microenvironment Characteristics and Immune Escape Mechanisms of Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2019)

Integrated Multi-Omics Data Analysis Reveals Associations Between Glycosylation and Stemness in Hepatocellular Carcinoma
por: Liu, Peiyan, et al.
Publicado: (2022)

Integrated multi-omics analysis identifies ENY2 as a predictor of recurrence and a regulator of telomere maintenance in hepatocellular carcinoma
por: Li, Jian-Hua, et al.
Publicado: (2022)

Identification of Gene-Set Signature in Early-Stage Hepatocellular Carcinoma and Relevant Immune Characteristics
por: Zhao, Qijie, et al.
Publicado: (2021)

Identification and Validation of Hub Genes Associated With Hepatocellular Carcinoma Via Integrated Bioinformatics Analysis
por: Wang, Sumei, et al.
Publicado: (2021)

Deep Learning-Based Multi-Omics Integration Robustly Predicts Relapse in Prostate Cancer
por: Wei, Ziwei, et al.
Publicado: (2022)

Integrating omics datasets with the OmicsPLS package
por: Bouhaddani, Said el, et al.
Publicado: (2018)

Integrative Multi−Omics Analysis Reveals Candidate Biomarkers for Oral Squamous Cell Carcinoma
por: Wan, Zhengqing, et al.
Publicado: (2022)

Screening and Identification of Human Endogenous Retrovirus-K mRNAs for Breast Cancer Through Integrative Analysis of Multiple Datasets
por: Wei, Yongzhong, et al.
Publicado: (2022)

Integrated multi-omics analysis of the clinical relevance and potential regulatory mechanisms of splicing factors in hepatocellular carcinoma
por: Zhao, Yu-jia, et al.
Publicado: (2021)

Tumor Immune Microenvironment Characterization in Hepatocellular Carcinoma Identifies Four Prognostic and Immunotherapeutically Relevant Subclasses
por: Gao, Xingxing, et al.
Publicado: (2021)

Identification and verification of prognostic cancer subtype based on multi-omics analysis for kidney renal papillary cell carcinoma
por: Wang, Baodong, et al.
Publicado: (2023)

Integrated systemic analysis of FAM72A to identify its clinical relevance, biological function, and relationship to drug sensitivity in hepatocellular carcinoma
por: Zhou, Qi, et al.
Publicado: (2022)

Multi-Omics Integration Reveals a Competitive Endogenous RNAs Network for the Identification of Progression Biomarkers and the Stratification of Patients Diagnosed With Nephroblastoma
por: Wang, Jingbo, et al.
Publicado: (2020)

Identification of a cuproptosis and copper metabolism gene–related lncRNAs prognostic signature associated with clinical and immunological characteristics of hepatocellular carcinoma
por: Yuan, Wei, et al.
Publicado: (2023)

Multi-Omic Analyses of the m(5)C Regulator ALYREF Reveal Its Essential Roles in Hepatocellular Carcinoma
por: Xue, Chen, et al.
Publicado: (2021)

SAA1 identified as a potential prediction biomarker for metastasis of hepatocellular carcinoma via multi-omics approaches
por: Li, Gang, et al.
Publicado: (2023)

Identification of DNA repair gene signature and potential molecular subtypes in hepatocellular carcinoma
por: Bai, Yi, et al.
Publicado: (2023)

Editorial: Multi-omic Data Integration in Oncology
por: Finotello, Francesca, et al.
Publicado: (2020)

Prediction of prognosis, immune infiltration, and personalized treatment of hepatocellular carcinoma by analysis of cuproptosis-related long noncoding RNAs and verification in vitro
por: Li, Shanbao, et al.
Publicado: (2023)

Analysis of cuproptosis in hepatocellular carcinoma using multi-omics reveals a comprehensive HCC landscape and the immune patterns of cuproptosis
por: Li, Xinqiang, et al.
Publicado: (2022)

Integration of multi-omics data reveals a novel hybrid breast cancer subtype and its biomarkers
por: Wang, Zhen-zhen, et al.
Publicado: (2023)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma
por: Yang, Bo, et al.
Publicado: (2020)

Deep Learning for Approaching Hepatocellular Carcinoma Ultrasound Screening Dilemma: Identification of α-Fetoprotein-Negative Hepatocellular Carcinoma From Focal Liver Lesion Found in High-Risk Patients
por: Zhang, Wei-bin, et al.
Publicado: (2022)

An integrative imputation method based on multi-omics datasets
por: Lin, Dongdong, et al.
Publicado: (2016)

Metabolism-related signatures is correlated with poor prognosis and immune infiltration in hepatocellular carcinoma via multi-omics analysis and basic experiments
por: Shen, Jiapei, et al.
Publicado: (2023)

Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma
por: Zhuang, Hongkai, et al.
Publicado: (2022)

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: Yu, Zhenjun, et al.
Publicado: (2021)

Editorial: Metabolism-based omics integrations, biosensors, and molecular mechanisms in human cancers
por: Yang, Yi-Fang, et al.
Publicado: (2023)

Identification of Mitochondrial-Related Prognostic Biomarkers Associated With Primary Bile Acid Biosynthesis and Tumor Microenvironment of Hepatocellular Carcinoma
por: Zhang, Tao, et al.
Publicado: (2021)

Comprehensive Study of Tumor Immune Microenvironment and Relevant Genes in Hepatocellular Carcinoma Identifies Potential Prognostic Significance
por: Chen, Wenbiao, et al.
Publicado: (2020)

The Autophagy Related Gene CHAF1B Is a Relevant Prognostic and Diagnostic Biomarker in Hepatocellular Carcinoma
por: Zhang, Zunni, et al.
Publicado: (2021)

Identifying Apoptosis-Related Transcriptomic Aberrations and Revealing Clinical Relevance as Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma
por: Zhu, Jinyu, et al.
Publicado: (2021)

Integrated Multi-Omics Analysis Model to Identify Biomarkers Associated With Prognosis of Breast Cancer
por: Fan, Yeye, et al.
Publicado: (2022)

Development and Validation of a Four Adenosine-to-Inosine RNA Editing Site-Relevant Prognostic Signature for Assessing Survival in Breast Cancer Patients
por: Wan, Jian, et al.
Publicado: (2022)

Identification and Validation of Tumor Stromal Immunotype in Patients With Hepatocellular Carcinoma
por: Li, Wei, et al.
Publicado: (2019)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma
por: Chen, Qinjunjie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_28bk3pge3a5lme85lenaovv1up